Use of second doses of Valtoco® (diazepam nasal spray) across 24 hours after the initial dose for out-of-hospital seizure clusters: Results from a phase 3, open-label, repeat-dose safety study

DIAZ.001.05 Study Group

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Use of second doses of Valtoco® (diazepam nasal spray) across 24 hours after the initial dose for out-of-hospital seizure clusters: Results from a phase 3, open-label, repeat-dose safety study'. Together they form a unique fingerprint.

Medicine & Life Sciences